65 studies found for:    vaccine niaid | Open Studies
Show Display Options
Rank Status Study
1 Recruiting A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-borne Encephalitis (TBE) for NIAID Workers Manipulating Tick Borne Encephalitis Virus (TBEV) in the Laboratory
Conditions: Tick-Borne Encephalitis;   Encephalitis, Tick-Borne;   Tick-Borne Disease;   Glycoprotein E, Flavivirus;   NSI Protein, Flavivirus
Intervention: Biological: FSME-IMMUN 0.5ml Baxter
2 Recruiting Screening Volunteers for Clinical Trials
Condition: Human Volunteers
Intervention:
3 Recruiting Volunteer Screening for Vaccine and Antivirals Clinical Trials
Condition: Healthy Volunteer
Intervention:
4 Recruiting Therapeutic Vaccine for HIV
Conditions: HIV;   Therapeutic Vaccine
Interventions: Biological: HIV-1 Multiantigen pDNA Vaccine;   Biological: Human IL-12 pDNA;   Procedure: In Vivo Electroporation using the TriGri;   Biological: rVSVIN HIV Gag Vaccine;   Biological: Placebo
5 Recruiting Immune Responses to Smallpox Vaccination
Condition: Smallpox Vaccine
Intervention:
6 Recruiting Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers
Conditions: Healthy Volunteer;   HIV Vaccine
Interventions: Biological: Ad4-mgag;   Biological: Ad4-EnvC150
7 Recruiting Intranasal AD4-H5-VTN as an Adenovirus Vaccine
Condition: Healthy Volunteer
Intervention: Biological: Ad4-H5-Vtn
8 Recruiting Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection
Conditions: Herpes Genitalis;   Herpes Simplex Virus;   Herpes Simplex Virus Vaccines;   HSV Vaccines;   Herpesvirus Vaccines
Interventions: Biological: Injection;   Procedure: Blood Draw;   Procedure: Clinical evaluation of herpes simplex diseases;   Procedure: Self swabbing for asymptomatic viral shedding;   Procedure: Collection of cervicovaginal secretions
9 Recruiting Experimental AD4-H5-VTN Vaccine in Healthy Volunteers
Condition: H5N1 Influenza
Interventions: Biological: Ad4-H5-VTN vaccination-tonsillar route;   Biological: Ad4-H5-vaccination-oral route
10 Recruiting Study of Controlled Human Malaria Infections to Evaluate Protection After Intravenous or Intramuscular Administration of PfSPZ Vaccine in Malaria-Na(SqrRoot) ve Adults
Conditions: Malaria;   Prevention and Control;   Acquired Immunity;   Parasitemia
Intervention: Biological: PfSPZ
11 Recruiting Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African Adults
Condition: Malaria
Intervention: Drug: PfSPZ
12 Recruiting Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies
Condition: Blood Component Removal
Intervention:
13 Recruiting Antibody Production in Immune Disorders
Condition: Immunologic Disease
Intervention:
14 Recruiting VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
Conditions: Immunity, Mucosal;   Immune System Processes;   Blood Specimen Collection
Intervention:
15 Not yet recruiting Collection of Biological Material From Pregnant Women in a Malarial Region
Condition: Malaria
Intervention:
16 Recruiting Normal Immunological Parameters Among Healthy Volunteers in Kambila, Mali
Condition: Malaria
Intervention:
17 Recruiting A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Condition: Pneumococcal Infection
Intervention: Biological: Prevnar 13 (PVC13)
18 Recruiting Safety of a Live Attenuated Human Parainfluenza Virus Type 2 (HPIV2) Vaccine for Adults, Children, and Infants
Condition: Human Parainfluenza Virus 2
Interventions: Biological: Standard Dose HPIV2 Vaccine;   Biological: Low dose HPIV2 vaccine;   Other: Placebo
19 Recruiting Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: TetraVax-DV Vaccine - Admixture TV003;   Biological: TetraVax-DV Vaccine - Admixture TV005;   Biological: Placebo
20 Not yet recruiting Evaluating the Safety and Immune Response to Three Different Prime-Boost HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA Nat-B env vaccine;   Biological: NYVAC Nat-B env vaccine;   Biological: DNA CON-S env vaccine;   Biological: NYVAC CON-S env vaccine;   Biological: DNA Mosaic env vaccine;   Biological: NYVAC Mosaic env vaccine;   Biological: Placebo;   Device: Biojector 2000® Needle-Free Injection Management System™ (Biojector 2000®)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years